Hiroko Kita

No ORCID on file · 1 paper in corpus
other 2022
Cancer biomarkers : section A of Disease markers ·doi:10.3233/cbm-210435

BACKGROUND: Ovarian clear cell carcinomas (OCCCs) have been recurrent and refractory among the present treatments, so novel therapeutics are urgently needed. OBJECTIVE: The present study accumulates the proof of concept to examine the feas…